New to the Board in 2024 are Lisa Bennet, Andrew Chang, and Brigitte Reutter-Haerle. Osamu Shirokizawa will serve another term. Directors completing their terms of service in 2023 are Javier Camposano and Mathias Romacker.
The complete 2024 Board of Directors and Officers will be composed of the following volunteers:
Officers
- Chairs: Anil Sawant, PhD, Merck & Co./Merck, Sharp & Dohme
- Chair-Elect: Melissa Seymour, MBA, Bristol Myers Squibb
- Treasurer: Emma Ramnarine, PhD, Boehringer-Ingelheim
- Secretary: Bettine Boltres, PhD, West Pharmaceutical Services
- Im. Past Chair: Sue Schniepp, Regulatory Compliance Associates Inc.
Directors
- Lisa Bennet, SeerPharma Pty Ltd.
- Christiana Campa, PhD, GSK
- Andrew Chang, PhD, Novo Nordisk
- Cylia Chen Ooi, Amgen
- Mirko Gabriele, PhD, InfiniteVision
- Marc Gloglovsky, ValSource Inc.
- Andrew Hopkins, Abbvie
- Stephan Krause, Bristol Myers Squibb
- Ivy Louis, VIENNI Training & Consulting LLP
- Amy McDaniel, Bristol Myers Squibb
- Brigitte Reutter-Haerle, Vetter Pharma
- Osamu Shirokizawa, Life Scientia Ltd.
Media Contact
Walter Morris, Parenteral Drug Association, 1 3016565900, [email protected], www.pda.org
SOURCE Parenteral Drug Association
